Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.
about
Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationTestosterone for the aging male; current evidence and recommended practiceThe benefits and risks of testosterone replacement therapy: a reviewEndocrine causes of nonalcoholic fatty liver diseaseCardiovascular effects of hormone therapy for prostate cancerSelection of the appropriate method for the assessment of insulin resistanceEndogenous sex hormones, metabolic syndrome, and diabetes in men and womenAndropause: Current conceptsPatient satisfaction with testosterone replacement therapies: the reasons behind the choicesHeart disease and stroke statistics--2011 update: a report from the American Heart AssociationHeart disease and stroke statistics--2012 update: a report from the American Heart AssociationTestosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study.Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies.Medical Manuscript: Serum Total Testosterone as a Prognostic Indicator in Male Patients With Terminal Cancer.Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?Lower SHBG level is associated with higher leptin and lower adiponectin levels as well as metabolic syndrome, independent of testosteroneNovel double-layer Silastic testicular prosthesis with controlled release of testosterone in vitro, and its effects on castrated rats.Late-onset hypogonadism.Testosterone regulates tight junction proteins and influences prostatic autoimmune responsesGenetic determinants of serum testosterone concentrations in men.Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS).Sertoli cells maintain Leydig cell number and peritubular myoid cell activity in the adult mouse testisThe role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart StudyTestosterone levels and type 2 diabetes in men: current knowledge and clinical implications.Endogenous testosterone and mortality in male hemodialysis patients: is it the result of aging?Testosterone Supplementation Improves Carbohydrate and Lipid Metabolism in Some Older Men with Abdominal Obesity.Effect of exercise on serum sex hormones in men: a 12-month randomized clinical trial.The association of time of day and serum testosterone concentration in a large screening population.Endocrinology of the aging male.Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.Huang-lian-jie-du-tang protects rats from cardiac damages induced by metabolic disorder by improving inflammation-mediated insulin resistance.Aging and exercise training reduce testes microvascular PO2 and alter vasoconstrictor responsiveness in testicular arterioles.Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart studyAutocrine androgen action is essential for Leydig cell maturation and function, and protects against late-onset Leydig cell apoptosis in both mice and men.Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis.Male obesity and subfertility, is it really about increased adiposity?Effects of sulfonylurea as initial treatment on testosterone of middle-aged men with type 2 diabetes: A 16-week, pilot studyAssociation of baseline sex hormone levels with baseline and longitudinal changes in waist-to-hip ratio: Multi-Ethnic Study of Atherosclerosis.Testosterone and metabolic syndrome: The link.
P2860
Q22306356-9707E5F7-C862-4329-9A66-9F9701E2E9A3Q24647679-E7C27193-020E-4FD9-A24A-595123714C67Q24658011-803574A0-065A-4FB9-B5DC-216AF4E3C6AFQ26780254-3376A49C-34E4-40D8-B722-4FB0D8E7534AQ26801112-7076F2C2-896E-49A7-9FAD-BF3880F40DADQ27001024-24D10BEC-95F1-451C-9332-49A24077A0D8Q27023901-537DEB77-780C-4F89-8434-DB3E942E0E24Q27024886-5300EDFF-2533-4EB5-9009-2431CBD64790Q28304192-33DBE1DB-A44E-4CFC-846A-49A6FE12634CQ29547236-C79F0AC6-8E1D-4FCB-BFA6-ED02D48D7CB0Q29547909-8421F750-94FA-44E8-A734-073C4C14F263Q30587292-50A248A0-1737-4B2F-926B-2094244E986FQ30836337-7182932E-70BD-400E-88D7-A45CA498616BQ33420679-AD552AB1-5656-470F-8046-0555E1C9C583Q33569163-8721BBB8-9A8F-46BB-B44B-4EC57CCEB21CQ33758814-C4193657-8A75-436B-A3D6-6E438359B0F0Q33897266-327945FA-DDE5-4BEE-B077-963B39BFB23EQ33903549-98CCA089-F48D-453A-B21C-BA4116CC5AA4Q33962057-CE46F25D-E1B0-4CCF-A0BA-CA12E5E8E13BQ34048108-7C2F6E4B-9204-47E9-ABB0-606D8AA07FD7Q34063853-F214B600-0399-41A5-9C83-9A28462B6C3CQ34075686-E06F5C61-5FD2-4B50-A25D-FDAA3BF21B27Q34097510-D1B8878A-60E8-4FB4-A181-D17AF3FD8FB0Q34165132-18418609-56CD-424C-B7BD-15FAE53B849BQ34398768-E8E4FEE3-8D73-4696-8C07-F6535A8FCB88Q34405392-715C69E0-9B9C-4E01-B8A4-92BD077307B5Q34479214-6C1B0AA2-0678-49FD-9EF9-E0982ABF219AQ34578422-8137584E-24D7-4BC4-B47F-2914FBAFD943Q34635438-85316B79-C32E-4364-8592-AA828B6D2B4BQ34777308-9DD11A7D-CB83-4284-9AE2-9E488B06B46EQ34804834-34BE4706-2276-4432-9593-D3489874B0C0Q34807603-45BB0C85-71FD-4870-B0E9-96ED5F051D6EQ35217432-3460F9DE-EC5B-4D9E-80BE-A57846B0B198Q35408545-609DF88A-6AF3-476B-BA7C-7D5B50A3C6E3Q35431241-C8BF4E23-B6F2-4376-B517-43D2AB1FFF10Q35432900-F0A470F1-E8FB-4704-A1E8-A330A27F7123Q35604409-CFB17B9F-A84D-49C5-B055-7042D7B10BB4Q35879329-1E8591CF-D2B9-4E71-BA3E-EFC19753EF28Q35928551-8C0B9BAD-3EF0-4A06-AC26-B1D281D11912Q35968107-AAFE7960-9DDE-425B-9BB5-DF9DAEA08215
P2860
Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Low sex hormone-binding globul ...... olic syndrome in nonobese men.
@en
Low sex hormone-binding globul ...... olic syndrome in nonobese men.
@nl
type
label
Low sex hormone-binding globul ...... olic syndrome in nonobese men.
@en
Low sex hormone-binding globul ...... olic syndrome in nonobese men.
@nl
prefLabel
Low sex hormone-binding globul ...... olic syndrome in nonobese men.
@en
Low sex hormone-binding globul ...... olic syndrome in nonobese men.
@nl
P2093
P356
P1476
Low sex hormone-binding globul ...... olic syndrome in nonobese men.
@en
P2093
Andre B Araujo
John B McKinlay
Stephanie T Page
Thomas G Travison
Varant Kupelian
William J Bremner
P304
P356
10.1210/JC.2005-1326
P407
P577
2006-01-04T00:00:00Z